Biosimilars: A Tipping Point

December 14, 2016

With biosimilars, the U.S. healthcare industry has a remarkable opportunity to make lifesaving and disease-altering drugs more accessible and more affordable. Read more.

Previous File
Achieving Success in Purchased Services
Achieving Success in Purchased Services

There is no denying cleaning up the purchased services space can be a daunting and seemingly impossible tas...

Next File
11 Principles for Hardwiring Labor Management
11 Principles for Hardwiring Labor Management